Lawmakers Push Bill to Speed Up Rare Disease Drugs

Millions of families wait years for cures that take too long. Testing new medicine takes massive budgets and precious time. Now, lawmakers want to speed up the process.

A new bipartisan bill helps drug companies run faster clinical trials. The plan cuts red tape to lower trial costs. It also makes tests easier for patients to join from home.

Rare conditions struggle to attract big research dollars. Smaller biotech firms carry most of the work. This bill gives these firms a clear path forward.

Faster trials help patients get lifesaving treatments sooner. For everyday investors, this move lowers risk for small biotech stocks and unlocks fresh growth.

Source: CNBC